HCPLive Cardiology Podcasts
HCPLive Cardiology Podcasts
HCPLive Cardiology
Finerenone's Role in Heart Failure from ESC Congress Data
15 minutes Posted Sep 2, 2024 at 4:25 pm.
Welcome and Introduction01:18 - FINEARTS-HF Study Design and Patient Population03:04 - Inclusion of Hospitalized Patients04:43 - Primary and Secondary Endpoints05:56 - Challenges in Achieving Statistical Significance07:39 - Health Status Improvement and Additional Analyses10:01 - Combination Therapy and Future Trials12:20 - Hyperkalemia and Steroidal vs. Non-Steroidal MRAs15:30 - Conclusion and Acknowledgments
0:00
15:39
Download MP3
Show notes
Live from ESC Congress 2024!In this edition of Don’t Miss a Beat, Stephen Greene, MD, an advanced heart failure specialist at Duke University School of Medicine, discusses the prospect of finerenone in treatment algorithms for heart failure with Muthiah Vaduganathan, MD, MPH, codirector of the Center for Cardiometabolic Implementation Science of Brigham and Women’s Hospital, based on data from the meeting, including FINEARTS-HF, FINE-HEART, and an analysis on MRA use in heart failure.Chapters00:00 - Welcome and Introduction01:18 - FINEARTS-HF Study Design and Patient Population03:04 - Inclusion of Hospitalized Patients04:43 - Primary and Secondary Endpoints05:56 - Challenges in Achieving Statistical Significance07:39 - Health Status Improvement and Additional Analyses10:01 - Combination Therapy and Future Trials12:20 - Hyperkalemia and Steroidal vs. Non-Steroidal MRAs15:30 - Conclusion and Acknowledgments